Ensysce Biosciences, Inc. - Common Stock, par value $0.0001 per share (ENSC)

Q: What does CUSIP 293602405 represent in this 13F holders report?

CUSIP 293602405 is the security identifier for ENSC - Ensysce Biosciences, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held ENSC - Ensysce Biosciences, Inc. - Common Stock, par value $0.0001 per share in Q1 2024?

9 institutional investors reported ENSC - Ensysce Biosciences, Inc. - Common Stock, par value $0.0001 per share for Q1 2024. Use the holders table for investor-level position and value details.

CUSIP: 293602405

Q1 2024 13F Holders as of 31 Mar 2024

Security type / class: Equity / Common Stock, par value $0.0001 per share
Total 13F shares: 299,747
Total 13F value: $236,512
Share change: +247,025
SEC-reported price per share: $0.79
Number of holders: 9
Value change: +$195,208
Number of buys: 6
Number of sells: 1
Shares outstanding: 19,603,857

Security key

293602405

Report period

Q1 2024

Institutions

Top holders

ENSC full security history Ownership snapshot Full 13F holder table Ensysce Biosciences, Inc. SEC filings Ensysce Biosciences, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of ENSC - Ensysce Biosciences, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

VANGUARD GROUP INC

Disclosed value leader

A. Lorne Weil

Comparable rows

7/15

Latest evidence

31 Dec 2023

13F 3/4/5 Lead comparable stake: 0.09% 8 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

VANGUARD GROUP INC leads the comparable SEC ownership view at 0.09%.

7 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VANGUARD GROUP INC's linked filing trail.

Comparable ownership Top 5

VANGUARD GROUP INC 0.09%

GEODE CAPITAL MANAGEMENT, LLC 0.08%

RENAISSANCE TECHNOLOGIES LLC 0.06%

Tower Research Capital LLC (TRC) 0.03%

BlackRock Finance, Inc. 0%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
VANGUARD GROUP INC	13F Company 13F	0.09%	$19,266 18,175 shares	—	31 Dec 2023
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	0.08%	$17,013 16,281 shares	—	31 Dec 2023
RENAISSANCE TECHNOLOGIES LLC	13F Company 13F	0.06%	$12,000 10,957 shares	—	31 Dec 2023
Tower Research Capital LLC (TRC)	13F Company 13F	0.03%	$6,685 6,307 shares	—	31 Dec 2023
BlackRock Finance, Inc.	13F Company 13F	0%	$1,034 975 shares	—	31 Dec 2023
WELLS FARGO & COMPANY/MN	13F Company 13F	0%	$25 24 shares	—	31 Dec 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

299,747

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q1 2024 Across Filers

Q1 2024 holders

Holder diff

Investor	Q1 2024 Shares	Q1 2024 Shares	Share Diff	Share Chg %	Q1 2024 value	Q1 2024 value	Value change	Value Chg %